Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

China · Delayed Price · Currency is CNY

2.880

-0.020 (-0.69%)

Jun 15, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Distribution	4.21B	4.75B	5.27B	5.28B	5.36B
Pharmaceutical Distribution Growth	-11.20%	-10.03%	-0.10%	-1.53%	10.44%
Medical Services	1.57B	1.64B	1.79B	1.86B	2.07B
Medical Services Growth	-3.75%	-8.48%	-3.90%	-10.18%	5.24%
Pharmaceutical Manufacturing	1.01B	938.69M	843.52M	790.26M	704.12M
Pharmaceutical Manufacturing Growth	7.64%	11.28%	6.74%	12.23%	16.05%
Other Industries	2.00M	2.09M	2.30M	8.61M	14.29M
Other Industries Growth	-4.07%	-9.30%	-73.25%	-39.77%	-21.29%
Consolidated Offset	-1.18B	-1.29B	-1.45B	-1.59B	-1.68B
Total	5.62B	6.03B	6.46B	6.35B	6.47B
Total Growth	-6.84%	-6.63%	1.75%	-1.88%	10.71%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Northeast	10.95M	15.64M	23.28M	24.46M	30.22M
Northeast Growth	-30.00%	-32.83%	-4.83%	-19.05%	34.93%
North China	63.33M	78.73M	94.84M	104.62M	112.57M
North China Growth	-19.56%	-16.99%	-9.35%	-7.06%	25.34%
East China	811.99M	730.94M	606.83M	529.11M	398.71M
East China Growth	11.09%	20.45%	14.69%	32.71%	37.62%
South China	9.89M	12.22M	11.84M	14.72M	12.43M
South China Growth	-19.02%	3.20%	-19.59%	18.40%	-63.83%
Central China	35.28M	39.44M	39.91M	39.66M	48.53M
Central China Growth	-10.54%	-1.18%	0.61%	-18.27%	14.36%
Northwest	5.12M	6.05M	7.06M	10.99M	12.13M
Northwest Growth	-15.36%	-14.24%	-35.79%	-9.39%	5.13%
Southwest	5.86B	6.44B	7.12B	7.22B	7.54B
Southwest Growth	-8.93%	-9.61%	-1.27%	-4.27%	8.90%
Consolidated Offset	-1.18B	-1.29B	-1.45B	-1.59B	-1.68B
Total	5.62B	6.03B	6.46B	6.35B	6.47B
Total Growth	-6.84%	-6.63%	1.75%	-1.88%	10.71%